InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

- Current share price for ATX : $0.150

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$77 Updated Investor Presentation 15 Sep 2021 8:59AM $0.200 $0.150 fallen by 25%
$77 Change of Director's Interest Notice - Jane Bell 6 Sep 2021 10:57AM $0.210 $0.150 fallen by 28.57%
$77 Results of Annual General Meeting 27 Aug 2021 3:00PM $0.205 $0.150 fallen by 26.83%
$77 AGM - Chief Executive Officer's Presentatioin 27 Aug 2021 11:39AM $0.205 $0.150 fallen by 26.83%
$77 Annual General Meeting Arrangements 20 Aug 2021 10:40AM $0.190 $0.150 fallen by 21.05%
$77 Quarterly Activities and Cashflow Reports and Presentation 28 Jul 2021 8:24AM $0.210 $0.150 fallen by 28.57%
$77 Shareholder Update and Presentation 26 Jul 2021 10:35AM $0.215 $0.150 fallen by 30.23%
$77 App 4G - Key to Corporate Governance Disclosures 23 Jul 2021 1:58PM $0.210 $0.150 fallen by 28.57%
$77 2021 Corporate Governance Statement 23 Jul 2021 1:42PM $0.210 $0.150 fallen by 28.57%
$77 Annual Report to Shareholders - YE 31 March 2021 23 Jul 2021 1:40PM $0.210 $0.150 fallen by 28.57%
$77 Notice of Annual General Meeting/Proxy Form 23 Jul 2021 1:39PM $0.210 $0.150 fallen by 28.57%
$77 Results from Successful Phase 1 Clinical Trial of AMP945 21 Jul 2021 8:21AM $0.210 $0.150 fallen by 28.57%
$77 Financial Report YE 31 March 2021 - Audited 29 Jun 2021 3:43PM $0.230 $0.150 fallen by 34.78%
$77 Amplia and Garvan Enter Into Collaboration Agreement 28 Jun 2021 8:32AM $0.225 $0.150 fallen by 33.33%
$77 Annual General Meeting to be Held 27 August 2021 25 Jun 2021 9:33AM $0.220 $0.150 fallen by 31.82%
$77 Change of Director's Interest - Dr. Lambert Exercise Options 8 Jun 2021 9:15AM $0.250 $0.150 fallen by 40%
$77 Application for quotation of securities - ATX 7 Jun 2021 5:14PM $0.250 $0.150 fallen by 40%
$77 Application for quotation of securities - ATX 7 Jun 2021 4:16PM $0.250 $0.150 fallen by 40%
$77 AMP945 Improves Survival in Pacnreatic Cancer Model 2 Jun 2021 8:45AM $0.205 $0.150 fallen by 26.83%
$77 Application for Quotation of Shares - Options Exercised 1 Jun 2021 4:18PM $0.205 $0.150 fallen by 26.83%
$77 App 4E - Preliminary Final Report YE 31 March 2021 31 May 2021 10:45AM $0.210 $0.150 fallen by 28.57%
$77 Change in substantial holding 11 May 2021 8:20AM $0.250 $0.150 fallen by 40%
$77 Section 708A Cleansing Notice - Share Placement 10 May 2021 5:15PM $0.250 $0.150 fallen by 40%
$77 Appendix 2A - Application for Quotation of Shares 10 May 2021 4:56PM $0.250 $0.150 fallen by 40%
$77 Appendix 3G - Notification of Issue of Securties - Options 10 May 2021 4:53PM $0.250 $0.150 fallen by 40%

351 - 375 of 538 results

Page 15 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.